1710MO Belzutifan for advanced pancreatic neuroendocrine tumors (panNETs): Results from cohort A2 of the phase II LITESPARK-015 study.
Saved in:
| Title: | 1710MO Belzutifan for advanced pancreatic neuroendocrine tumors (panNETs): Results from cohort A2 of the phase II LITESPARK-015 study. |
|---|---|
| Authors: | Capdevila, J.1 (AUTHOR), Artamonova, E.2 (AUTHOR), de Jesus Acosta, A.3 (AUTHOR), Niccoli, P.4 (AUTHOR), Toth, M.5 (AUTHOR), Ramirez, R.A.6 (AUTHOR), Hendifar, A.7 (AUTHOR), Cingarlini, S.8 (AUTHOR), Trikalinos, N.9 (AUTHOR), Quante, M.10 (AUTHOR), Garcia-Carbonero, R.11 (AUTHOR), Goker, E.12 (AUTHOR), Del Rivero, J.13 (AUTHOR), Eads, J.14 (AUTHOR), Odeleye-Ajakaye, A.T.15 (AUTHOR), Gozman, A.16 (AUTHOR), Naik, G.16 (AUTHOR), Spada, F.17 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1008-S1009. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.2338 |
